Our previous studies suggest that a failure to degrade aggregated A␤1-42 in late endosomes or secondary lysosomes is a mechanism that contributes to intracellular accumulation in Alzheimer's disease. In this study, we demonstrate that cultured primary neurons are able to internalize soluble A␤1-42 from the culture medium and accumulate inside the endosomal/lysosomal system. The intracellular A␤1-42 is resistant to protease degradation and stable for at least 48 h within the cultured neurons. Incubation of cultured neurons with a cytotoxic concentration of soluble A␤1-42 invokes the rapid free radical generation within lysosomes and disruption of lysosomal membrane proton gradient which precedes cell death. The loss of lysosomal membrane impermeability is only specific to the A␤1-42 isoform since incubation of cells with high concentrations of A␤1-40 has no effect on lysosomal hydrolase release. To further support the role of lysosomal membrane damage in A␤-mediated cell death, we demonstrate that photodisruption of acridine orange (AO)-loaded lysosomes with intense blue light induces a relatively rapid synchronous lysosomal membrane damage and neuronal death similar to that observed as a result of A␤ exposure. AO leaks quickly from late endosomes and lysosomes and partially shifts the fluorescence from an orange fluorescence to a diffuse, green cytoplasmic fluorescence. Such AO relocalization is due to an initial disruption of the lysosomal proton gradient, followed by the release of lysosomal hydrolases into the cytoplasmic compartment. Treatment of cells with either the antioxidant n-propyl gallate or lysosomotropic amine (methylamine) partially blocks the release of lysosomal contents suggesting that this AO relocalization is due to lysosomal membrane oxidation. Based on these findings, we propose that the cell death mediated by the soluble A␤ may be fundamentally different from the cell loss observed following extracellular A␤ deposition.
INTRODUCTION
One of major pathological hallmarks of Alzheimer's disease is the accumulation of extracellular amyloid plaques. The major proteinaceous component of plaques is an x-42(43) amino acid, self-assembling protein known as ␤-amyloid (Selkoe, 1994) . Previous studies indicate that internalized A␤1-42 is largely degradation resistant and accumulates as insoluble aggregates in late endosomes or secondary lysosomes in a variety of cells (Burdick et al., 1997; Knauer et al., 1992) . Although A␤1-40 and shorter peptides are also internalized via endocytosis, these peptides turn over much more rapidly and fail to accumulate within the cell (Burdick et al., 1997; Knauer et al., 1992) . The amyloid precursor protein (APP) is normally degraded rapidly in lysosomes (Estus et al., 1992a,b; Golde et al., 1992) . However, the presence of insoluble, degradation-resistant A␤1-42 within lysosomes establishes a prion-like autocatalytic cycle that results in a dramatic increase in the levels of insoluble, potentially amyloidogenic APP C-terminal fragments and A␤, molecules which are also poorly degraded (Yang et al., 1995) . APP carboxyl-terminal fragments have also been detected in both Alzheimer's disease (AD) and aged control brains (Estus et al., 1992a,b) . As a result,
